Growth Metrics

Omeros (OMER) Non-Current Deffered Revenue (2012 - 2018)

Omeros recorded quarterly Non-Current Deffered Revenue of $8.2 million in Q4 2018, down 1.78% quarter-over-quarter from $8.3 million in Q3 2018, and down 6.21% year-over-year from $8.7 million in Q4 2017.

Omeros' Non-Current Deffered Revenue history runs 7 years deep, the most recent figure standing at $8.2 million for Q4 2018.

  • In Q4 2018, Non-Current Deffered Revenue fell 6.21% year-over-year to $8.2 million; the TTM figure through Dec 2018 stood at $8.2 million (down 6.21% YoY), while the FY2018 annual figure was $8.2 million, down 6.21% from the prior year.
  • Non-Current Deffered Revenue came in at $8.2 million for Q4 2018 at Omeros, down from $8.3 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $9.2 million in Q1 2016 to a low of $8.2 million in Q4 2018.
  • A 5-year average of $8.9 million and a median of $9.0 million in 2017 frame the typical range for Non-Current Deffered Revenue.
  • Across the five-year window, Non-Current Deffered Revenue surged 122.99% in 2014 and decreased 6.21% in 2018, its largest moves.
  • Omeros' Non-Current Deffered Revenue stood at $9.0 million in 2014, then advanced by 1.73% to $9.2 million in 2015, then fell by 0.71% to $9.1 million in 2016, then decreased by 4.64% to $8.7 million in 2017, then fell by 6.21% to $8.2 million in 2018.
  • According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $8.2 million, $8.3 million, and $8.5 million for Q4 2018, Q3 2018, and Q2 2018 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 225.10 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Omeros 772.03 Mn 636.71 Mn 9.31 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2018 8.18 Mn
Sep 30, 2018 8.33 Mn
Jun 30, 2018 8.45 Mn
Mar 31, 2018 8.58 Mn
Dec 31, 2017 8.72 Mn
Sep 30, 2017 8.84 Mn
Jun 30, 2017 8.94 Mn
Mar 31, 2017 9.04 Mn
Dec 31, 2016 9.14 Mn
Sep 30, 2016 9.19 Mn
Jun 30, 2016 9.21 Mn
Mar 31, 2016 9.22 Mn
Dec 31, 2015 9.21 Mn
Sep 30, 2015 9.17 Mn
Jun 30, 2015 9.13 Mn
Mar 31, 2015 9.09 Mn
Dec 31, 2014 9.05 Mn
Sep 30, 2014 8.94 Mn
Jun 30, 2014 8.67 Mn
Mar 31, 2014 8.41 Mn
Dec 31, 2013 8.15 Mn
Sep 30, 2013 7.63 Mn
Jun 30, 2013 6.61 Mn
Mar 31, 2013 3.77 Mn
Dec 31, 2012 4.64 Mn
Sep 30, 2012 3.09 Mn
Jun 30, 2012 3.01 Mn
Mar 31, 2012 3.06 Mn